Clinical Trial Update: Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This entry reports an ongoing Phase 1/2 clinical trial evaluating a triple-drug regimen of lenalidomide, venetoclax, and obinutuzumab in treatment-naïve follicu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Gazyva (Obinutuzumab)
• Revlimid (lenalidomide)
• Venclexta (venetoclax)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Follicular Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING